Targetting the use of beta 2-adrenoceptor agonists to meet physiological and rule book requirements.
Nolan
A
A
McKellar
Q
Q
D000280:Administration, Inhalation; D000284:Administration, Oral; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D016084:Bronchoconstriction / Q000187:drug effects / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D006734:Horse Diseases / Q000188:drug therapy / Q000503:physiopathology; D006736:Horses / Q000502:physiology*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy / Q000503:physiopathology / Q000662:veterinary; D009119:Muscle Contraction / Q000187:drug effects* / Q000502:physiology; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology
D000318:Adrenergic beta-Agonists